Radiolabeled AOMK Probes for Cysteine Protease Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current imaging methods lack effective radiological agents for visualizing cysteine cathepsin and caspase activity, which are crucial for understanding tumor progression and metastasis, due to the difficulty in designing radioactive probes that can selectively target these proteases.
Innovation Solution
Development of radiolabeled small molecule activity-based probes with a reactive acyloxymethyl ketone (AOMK) group that covalently target cysteine cathepsins and caspases, utilizing a positron emitter like 64Cu for PET imaging, allowing for selective visualization of tumors with high cysteine protease activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radiolabeled probes are designed to target cysteine cathepsins and caspases, then tumor imaging capability is improved, but probe design complexity and selectivity challenges increase
Solution Approach 1:
The probe is segmented into distinct functional modules: a radiolabeling moiety for detection, a peptide sequence for protease recognition and binding, and a linker connecting these components. This modular design allows independent optimization of each function while simplifying the overall design process.
Solution Approach 2:
The peptide sequence acts as an intermediary that specifically recognizes and binds to cysteine cathepsins and caspases. This intermediary component enables selective targeting of tumor-associated proteases while the radiolabel provides detection capability, resolving the complexity of designing a single molecule with both functions.
2Measurement precision
If optical imaging probes are used for protease activity visualization, then protease activity detection is improved, but translation to radiological imaging is limited
Solution Approach 1:
The probe design incorporates a universal platform that can accommodate different radiolabels (e.g., fluorine-18, gallium-68) while maintaining the same peptide targeting sequence. This multi-functionality allows the same probe structure to be adapted for various radiological imaging applications, bridging the gap between optical and radiological imaging methodologies.
3Measurement precision
If substrate-based probes are used for protease targeting, then catalytic signal amplification is improved, but probe stability and background signal increase
Solution Approach 1:
The probe design converts the potential harm of substrate cleavage (which could lead to background signal) into a beneficial detection mechanism. The probe is designed as a substrate that, when cleaved by active proteases, releases or activates the radiolabeled signal, thereby converting enzyme activity into a measurable signal while maintaining probe stability through careful molecular design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The probes demonstrate good tumor-to-background contrast and correlate with cysteine cathepsin activity levels, enabling effective PET imaging of tumors with high cysteine protease expression, potentially aiding in cancer diagnosis and treatment stratification.
Implementation Method 1
utilizing a positron emitter like 64Cu for PET imaging
Implementation Method 2
radiolabeled small molecule activity-based probes with a reactive acyloxymethyl ketone (AOMK) group that covalently target cysteine cathepsins and caspases
Data Source
AI summary
Activity-based probes, which are specific for certain active cysteine proteases (caspase, cathepsin and legumain) and carry radioactive labels, are disclosed. The present probes comprise an acyloxymethyketone (AOMK) “warhead” that binds only to active enzyme. The probes further comprise peptide-like structure that targets the probe to a specific cysteine protease or protease family, and a radiolabel on the probe, which is bound to the targeted enzyme. It has been found that the present probes are stable in vivo and give specific target images distinguishable over background. The preferred probes are labeled with a positron-emitting agent such as 64Cu, 125I (SPECT) and 99mTc (PET). The probes show in vivo half-life and stability well suited for imaging.